The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients
This study has been completed.
Sponsor:
Astellas Pharma Inc
Collaborators:
Severance Hospital
Yonsei University
Information provided by:
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT01061060
First received: February 1, 2010
Last updated: November 2, 2010
Last verified: November 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2010 |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |